These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17474825)

  • 1. Comment on "lithium and clozapine rechallenge: a retrospective case analysis".
    Esposito D
    J Clin Psychiatry; 2007 Apr; 68(4):635; author reply 635. PubMed ID: 17474825
    [No Abstract]   [Full Text] [Related]  

  • 2. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA; Kerwin RW
    J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be Risky.
    Boazak M; Goldsmith DR; Cotes RO
    Prim Care Companion CNS Disord; 2018 Nov; 20(6):. PubMed ID: 30549484
    [No Abstract]   [Full Text] [Related]  

  • 4. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of clozapine induced agranulocytosis 25 years after starting treatment: Effective use of lithium for augmentation in rechallenge.
    Martina AC; Ee JS; Lamberti JS
    Schizophr Res; 2019 Aug; 210():308-309. PubMed ID: 31277977
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract]   [Full Text] [Related]  

  • 8. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P; Slater S; Measham T; Koch M; Wiviott G
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of rechallenge clozapine after agranulocytosis: A case report.
    Roméo B; Petillion A; Martelli C; Benyamina A
    Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine-Associated Neutropenia and Agranulocytosis.
    Andres E; Mourot-Cottet R
    J Clin Psychopharmacol; 2017 Dec; 37(6):749-750. PubMed ID: 29040154
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
    Silva E; Higgins M; Hammer B; Stephenson P
    BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of lithium in clozapine-induced neutropenia: a case report.
    Suraweera C; Hanwella R; de Silva V
    BMC Res Notes; 2014 Sep; 7():635. PubMed ID: 25214394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP
    Tijdschr Psychiatr; 2007; 49(8):575-9. PubMed ID: 17694491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL; Yim PH
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical pattern of haematological risk with clozapine.
    Gillman K
    Br J Psychiatry; 2000 Jul; 177():88. PubMed ID: 10945101
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing outcomes in clozapine rechallenge following neutropenia using human leukocyte antigen typing: A case report.
    Yamaki N; Hishimoto A; Otsuka I; Sasada T; Boku S; Saito T; Yasuda Y; Yamamori H; Ikeda M; Ikeda M; Sora I; Iwata N; Hashimoto R
    Psychiatry Clin Neurosci; 2017 Apr; 71(4):289-290. PubMed ID: 28097743
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride).
    Ruiz-Doblado S; Plasencia-García de Diego B; Perea-Pérez R; Jiménez-Gonzalo F
    Actas Esp Psiquiatr; 2020 Mar; 48(2):89-91. PubMed ID: 32463914
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N; Myles H; Clark SR; Bird R; Siskind D
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.